BioNano Genomics Inc vs Church & Dwight Co., Inc. — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while Church & Dwight Co., Inc. trades at $103.35 (market cap $24.38B). The key difference: Church & Dwight Co., Inc. is far larger — about 1784.8× BioNano Genomics Inc's market cap, and Church & Dwight Co., Inc. pays a 1.2% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | CHD | |
|---|---|---|
Market Cap | $13.66M | $24.38B |
Sector | Health | Consumer Staples |
52-Week High | $4.92 | $105.26 |
52-Week Low | $1.06 | $81.60 |
Enterprise Value | $16.26M | $26.38B |
Dividend Yield | — | 1.2% |
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Church & Dwight is the leading producer of baking soda in the world. Beyond baking soda, the products in its portfolio have vast category reach, including laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Xtra, Trojan, OxiClean, First Response, Nair, L'il Critters/Vitafusion, Orajel, and WaterPik, which together with Arm & Hammer constitute more than 80% of its annual sales and profits. In early 2019, the firm announced the addition of Flawless, which manufactures electric shaving products for women. At the end of 2020, the firm acquired Zicam, a leading brand in the cough/cold-shortening category. Church & Dwight derives more than 80% of its sales from its home market in the U.S.
Read more on CHD →